Navigation Links
MIT researcher addresses biomedical engineering challenges
Date:2/15/2008

CAMBRIDGE, Mass. Much of the work in MIT Institute Professor Robert Langers prolific lab sounds like something straight from the pages of science fiction, but its products are already saving lives around the world in a variety of ways.

One of Langers specialties is growing the vital tissues of the human bodyincluding skin, blood vessels, bone and parts of organs such as the liver and intestinesin a laboratory dish instead of in the body. For example, based on Langers work scientists can grow patches of skin that can be used as grafts for burn victims.

Langer will speak about the great challenges facing biomedical engineering in the next century, at the annual meeting of the American Association for the Advancement of Science (AAAS) in Boston, on Friday afternoon, Feb. 15. The talk is part of a special session announcing a National Academy of Engineering report put together by a committee of 18 leading researchers in a variety of disciplines, including Langer, and reviewed by more than 60 experts. The report, titled Grand Challenges for Engineering, describes the areas of research that are seen as most likely to produce results that could dramatically improve life on Earth.

The report will be unveiled at a press conference at 2 p.m. EST on Friday, Feb. 15, at the AAAS meeting. In addition to Langer, two other MIT scientists were members of the panel and will participate in the press conference: Wesley L. Harris, the Charles Stark Draper Professor of Aeronautics and Astronautics at MIT and a former NASA associate administrator, and MIT President Emeritus Charles Vest, a professor in the Department of Mechanical Engineering.

Among the grand challenges in the area of biomedical engineering, Langer says, is finding new ways of delivering drugs and other large molecules to targeted sites inside the human body.

As part of that research, Langer, who already has more than 600 patents granted or pending, has been working on the development of novel ways to introduce DNA strands into human cells, a necessary step in gene therapy to correct genetic abnormalities or predispositions to disease.

Traditionally, such DNA insertions have been carried out using viruses that have a natural ability to penetrate the cell and insert segments of DNA into the nucleus. But these viruses can sometimes have dangerous side effects, and have been responsible for deaths in some early gene-therapy trials.

Were working on polymers that could deliver DNA as efficiently as viruses, that could put a DNA strand wherever you want, without the safety problems of viruses, Langer says. In addition, they could be cheaper and easier to manufacture.

So far, the problem has been that such synthetic vectors have been far less efficient in carrying out the delivery. But in early tests conducted by Jordan Green and Dan Anderson in Langers lab, some polymers have been as effective at delivering the DNA strands to their target as the viruses, but with 100 times less toxicity.

Such new polymers, Langer says, might eventually lead to new treatments for some kinds of cancer. And they may also enable the delivery of small interfering RNA segments (siRNAs), whose discovery led to a Nobel Prize in 2006. These may be used to combat a variety of diseases.

Anderson, Langer and graduate student Michael Goldberg have also been working on the design of chemicals similar to lipids in the body, called lipidoids that could be used to deliver drugs including siRNA to specific tissues in the body and release them in a controlled way. Already more than 50 promising compounds have been found and are undergoing tests. That work is going quite well, Langer says.

Tissue engineering is another important area of ongoing research, Langer says. One key project is growing replacements for damaged tissues such as the neurons damaged by spinal cord injuries that lead to paralysis. Using a neuronal scaffold, Langer and his collaborators have succeeded in growing new tissue from neuronal stem cells, and have succeeded in helping paralyzed mice to walk again.


'/>"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
Source:Eurekalert

Related biology technology :

1. Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
2. A researcher of UPV/EHU has designed nanomagnets for industry
3. Stanford researchers hear the sound of quantum drums
4. Researchers at Leeds mine the Terahertz gap
5. Researchers create gold aluminum, black platinum, blue silver
6. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
7. Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections
8. Researchers develop darkest manmade material
9. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
10. Researchers use magnetism to target cells to animal arteries
11. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):